BioAmp Diagnostics develops biochemical tests intended to provide faster antibiotic-resistance information to clinicians and laboratories.
BioAmp Diagnostics develops biochemical diagnostics intended to identify antibiotic resistance. Its initial application targets complicated urinary tract infections, where earlier resistance information could inform antibiotic selection.
Its DETECT platform uses an enzyme-triggered chemical reaction to produce a measurable signal. BioAmp has also proposed adapting the approach to laboratory susceptibility-testing systems.
Loading profile details…
Biotech Research · Business involvement
As of 2026-11-08
Loading recent changes…
Editorial profile by MoneyMakers. Sources reviewed .
Brand marks identify the organization. Logo from the official website.
CEO
Chief executive officer of BioAmp Diagnostics.
View personal profile